These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Adding Additional Acute Medications to a Triptan Regimen for Migraine and Observed Changes in Headache-Related Disability: Results From the American Migraine Prevalence and Prevention (AMPP) Study. Buse DC; Serrano D; Reed ML; Kori SH; Cunanan CM; Adams AM; Lipton RB Headache; 2015 Jun; 55(6):825-39. PubMed ID: 25881857 [TBL] [Abstract][Full Text] [Related]
5. Symptomatic treatment of migraine: from scientific evidence to patient management. Manzoni GC; Torelli P Neurol Sci; 2014 May; 35 Suppl 1():11-5. PubMed ID: 24867828 [TBL] [Abstract][Full Text] [Related]
6. [Rizatriptan: experience after 15 years of clinical use]. Ramón-Carbajo C; Alvarez-Escudero R; Pascual J Rev Neurol; 2013 Dec; 57(12):549-55. PubMed ID: 24288104 [TBL] [Abstract][Full Text] [Related]
7. Triptans in the Acute Treatment of Migraine: A Systematic Review and Network Meta-Analysis. Cameron C; Kelly S; Hsieh SC; Murphy M; Chen L; Kotb A; Peterson J; Coyle D; Skidmore B; Gomes T; Clifford T; Wells G Headache; 2015; 55 Suppl 4():221-35. PubMed ID: 26178694 [TBL] [Abstract][Full Text] [Related]
8. SumaRT/Nap vs naproxen sodium in treatment and disease modification of migraine: a pilot study. Cady R; O'Carroll P; Dexter K; Freitag F; Shade CL Headache; 2014 Jan; 54(1):67-79. PubMed ID: 24021029 [TBL] [Abstract][Full Text] [Related]
9. The experience of combining agents, specially triptans and non steroidal anti-inflammatory drugs, for the acute treatment of migraine - a review. Krymchantowski AV; Jevoux Cda C Recent Pat CNS Drug Discov; 2007 Jun; 2(2):141-4. PubMed ID: 18221225 [TBL] [Abstract][Full Text] [Related]
10. Treatment of chronic migraine: a 3-month comparator study of naproxen sodium vs SumaRT/Nap. Cady R; Nett R; Dexter K; Freitag F; Beach ME; Manley HR Headache; 2014 Jan; 54(1):80-93. PubMed ID: 24020994 [TBL] [Abstract][Full Text] [Related]
11. Effects of switching acute treatment on disability in migraine patients using triptans. Serrano D; Buse DC; Kori SH; Papapetropoulos S; Cunanan CM; Manack AN; Reed ML; Lipton RB Headache; 2013 Oct; 53(9):1415-29. PubMed ID: 23808937 [TBL] [Abstract][Full Text] [Related]
12. Frovatriptan review. Markus F; Mikko K Expert Opin Pharmacother; 2007 Dec; 8(17):3029-33. PubMed ID: 18001261 [TBL] [Abstract][Full Text] [Related]
13. Glutamate levels in cerebrospinal fluid and triptans overuse in chronic migraine. Vieira DS; Naffah-Mazzacoratti Mda G; Zukerman E; Senne Soares CA; Cavalheiro EA; Peres MF Headache; 2007 Jun; 47(6):842-7. PubMed ID: 17578532 [TBL] [Abstract][Full Text] [Related]
14. Acute migraine treatment with oral triptans and NSAIDs in a managed care population. Ng-Mak DS; Hu XH; Chen YT; Ma L Headache; 2008 Sep; 48(8):1176-85. PubMed ID: 18819177 [TBL] [Abstract][Full Text] [Related]
15. Intranasal zolmitriptan for the treatment of acute migraine. Tepper SJ; Chen S; Reidenbach F; Rapoport AM Headache; 2013 Sep; 53 Suppl 2():62-71. PubMed ID: 24024604 [TBL] [Abstract][Full Text] [Related]
16. Combination of NSAID and Triptan in Migraine Treatment and Cardiovascular Risk: Is It Safe? Maggioni F; Terrin A; Maggioni G; Mainardi F Headache; 2017 Nov; 57(10):1622-1623. PubMed ID: 29124758 [No Abstract] [Full Text] [Related]
17. Evidences of Reduced Antioxidant Activity in Patients With Chronic Migraine and Medication-Overuse Headache. Lucchesi C; Baldacci F; Cafalli M; Chico L; Lo Gerfo A; Bonuccelli U; Siciliano G; Gori S Headache; 2015; 55(7):984-91. PubMed ID: 26129705 [TBL] [Abstract][Full Text] [Related]
18. Sumatriptan plus naproxen for acute migraine attacks in adults. Law S; Derry S; Moore RA Cochrane Database Syst Rev; 2013 Oct; (10):CD008541. PubMed ID: 24142431 [TBL] [Abstract][Full Text] [Related]